Response

Affiliations

¹ Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada. Electronic address: raymaker@mail.ubc.ca.
² Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada; Division of Respiratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
³ Centre for Heart and Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.
⁴ Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
⁵ Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada; Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, BC, Canada.

Comment

Adam J N Raymakers et al. Chest. 2018 Feb.

. 2018 Feb;153(2):578-579.

doi: 10.1016/j.chest.2017.12.006.

¹ Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada. Electronic address: raymaker@mail.ubc.ca.
² Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada; Division of Respiratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
³ Centre for Heart and Lung Innovation, St. Paul's Hospital, Vancouver, BC, Canada.
⁴ Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
⁵ Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada; Centre for Health Evaluation and Outcome Sciences, St. Paul's Hospital, Vancouver, BC, Canada.

No abstract available

Comment on

The Impact of Statin Drug Use on All-Cause Mortality in Patients With COPD: A Population-Based Cohort Study.
Raymakers AJN, Sadatsafavi M, Sin DD, De Vera MA, Lynd LD. Raymakers AJN, et al. Chest. 2017 Sep;152(3):486-493. doi: 10.1016/j.chest.2017.02.002. Epub 2017 Feb 12. Chest. 2017. PMID: 28202342
Statins in COPD: Selection Modalities and Mortalities.
Sakhamuri S, Chattu VK. Sakhamuri S, et al. Chest. 2018 Feb;153(2):578. doi: 10.1016/j.chest.2017.09.057. Chest. 2018. PMID: 29406229 No abstract available.